Our expert eye
Take a look at the experts and opinions that make Kindeva the leading CDMO in the industry.Learn more
St. Paul, MN (November 15, 2021) – Kindeva Drug Delivery (Kindeva) announced that Steve Fuechtmann has joined Kindeva’s Leadership Team as the Chief Financial Officer. Steve is joining Kindeva with 25+ years of progressive experience in Finance, Accounting, Treasury, IT, Operations and Strategic planning.
He most recently served as the CFO of Jack Links for 4 years in Minneapolis and has progressive levels of responsibility at the Schwan Food Company, Ecolab, Best Buy, and Arthur Andersen prior to that.
“Throughout his career, Steve has demonstrated that he is a values-based leader who partners very closely with the businesses that he supports to drive transformational improvements in operational and financial performance,” said Aaron Mann, CEO of Kindeva.
“I am thrilled to be joining Kindeva and the extremely talented, driven, and ethical team that is in place,” said Steve Fuechtmann. “It’s an exciting time for the company as we continue to take on increasingly complex drug delivery challenges and programs, in partnership with our global biopharmaceutical customers.”
Steve graduated from St. John’s University in Collegeville, MN with a BA in Accounting and Management.
About Kindeva Drug Delivery
Headquartered in St. Paul, Minnesota, Kindeva Drug Delivery is a leading global contract development and manufacturing organization (CDMO) in the pharmaceutical industry. Kindeva provides unique technologies and quality services to its customers, ranging from formulation and product development to commercial manufacturing. Kindeva focuses on complex drug programs, and its current offering spans inhalation drug delivery, transdermal drug delivery, microstructured transdermal systems (microsystems), and connected drug delivery. Kindeva employs approximately 1,000 people worldwide. For more information, visit www.kindevadd.com.